Delcath Systems PE Ratio 2010-2024 | DCTH
Current and historical p/e ratio for Delcath Systems (DCTH) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Delcath Systems PE ratio as of December 20, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Delcath Systems PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-12-20 | 11.01 | 0.00 | |
| 2024-09-30 | 9.03 | $-1.35 | 0.00 |
| 2024-06-30 | 8.37 | $-2.55 | 0.00 |
| 2024-03-31 | 4.77 | $-2.65 | 0.00 |
| 2023-12-31 | 4.16 | $-2.97 | 0.00 |
| 2023-09-30 | 4.05 | $-3.35 | 0.00 |
| 2023-06-30 | 5.83 | $-3.13 | 0.00 |
| 2023-03-31 | 5.75 | $-3.73 | 0.00 |
| 2022-12-31 | 3.60 | $-3.96 | 0.00 |
| 2022-09-30 | 3.20 | $-3.79 | 0.00 |
| 2022-06-30 | 3.99 | $-3.81 | 0.00 |
| 2022-03-31 | 6.40 | $-3.59 | 0.00 |
| 2021-12-31 | 7.75 | $-3.63 | 0.00 |
| 2021-09-30 | 10.44 | $-3.55 | 0.00 |
| 2021-06-30 | 12.61 | $-3.77 | 0.00 |
| 2021-03-31 | 12.42 | $-4.71 | 0.00 |
| 2020-12-31 | 17.92 | $-111.74 | 0.00 |
| 2020-09-30 | 11.61 | $-111.13 | 0.00 |
| 2020-06-30 | 10.25 | $-1,117.11 | 0.00 |
| 2020-03-31 | 0.10 | $-1,172.36 | 0.00 |
| 2019-12-31 | 0.10 | $-1,142.86 | 0.00 |
| 2019-09-30 | 69.93 | $-1,142.86 | 0.00 |
| 2019-06-30 | 69.93 | $-314.29 | 0.00 |
| 2019-03-31 | 69.93 | $-5,442.86 | 0.00 |
| 2018-12-31 | 69.93 | $2,428.57 | 0.03 |
| 2018-09-30 | 69.93 | $2,428.57 | 0.03 |
| 2018-06-30 | 69.93 | $-3,340,249.86 | 0.00 |
| 2018-03-31 | 34965.00 | $-4,566,591.14 | 0.00 |
| 2017-12-31 | 34965.00 | $-35,362,564.00 | 0.00 |
| 2017-09-30 | 12237762.24 | $-555,066,964.00 | 0.00 |
| 2017-06-30 | 24132524.13 | $-633,004,897.00 | 0.00 |
| 2017-03-31 | 10743260.74 | $-1,174,876,770.00 | 0.00 |
| 2016-12-31 | 100000000.00 | $-1,301,724,090.00 | 0.00 |
| 2016-09-30 | 100000000.00 | $-1,235,221,690.00 | 0.00 |
| 2016-06-30 | 100000000.00 | $-1,390,394,100.00 | 0.00 |
| 2016-03-31 | 100000000.00 | $-1,438,423,700.00 | 0.00 |
| 2015-12-31 | 100000000.00 | $-1,911,330,000.00 | 0.00 |
| 2015-09-30 | 100000000.00 | $-2,068,965,400.00 | 0.00 |
| 2015-06-30 | 100000000.00 | $-2,778,325,000.00 | 0.00 |
| 2015-03-31 | 100000000.00 | $-3,187,191,999.00 | 0.00 |
| 2014-12-31 | 100000000.00 | $-3,556,650,198.00 | 0.00 |
| 2014-09-30 | 100000000.00 | $-3,945,812,797.00 | 0.00 |
| 2014-06-30 | 100000000.00 | $-3,999,999,996.00 | 0.00 |
| 2014-03-31 | 100000000.00 | $-3,999,999,996.00 | 0.00 |
| 2013-12-31 | 100000000.00 | $-3,999,999,996.00 | 0.00 |
| 2013-09-30 | 100000000.00 | $-3,999,999,996.00 | 0.00 |
| 2013-06-30 | 100000000.00 | $-3,999,999,996.00 | 0.00 |
| 2013-03-31 | 100000000.00 | $-3,999,999,996.00 | 0.00 |
| 2012-12-31 | 100000000.00 | $-3,999,999,996.00 | 0.00 |
| 2012-09-30 | 100000000.00 | $-3,999,999,996.00 | 0.00 |
| 2012-06-30 | 100000000.00 | $-3,999,999,996.00 | 0.00 |
| 2012-03-31 | 100000000.00 | $-3,999,999,996.00 | 0.00 |
| 2011-12-31 | 100000000.00 | $-3,999,999,996.00 | 0.00 |
| 2011-09-30 | 100000000.00 | $-3,999,999,996.00 | 0.00 |
| 2011-06-30 | 100000000.00 | $-3,999,999,996.00 | 0.00 |
| 2011-03-31 | 100000000.00 | $-3,999,999,996.00 | 0.00 |
| 2010-12-31 | 100000000.00 | $-3,999,999,996.00 | 0.00 |
| 2010-09-30 | 100000000.00 | $-3,999,999,996.00 | 0.00 |
| 2010-06-30 | 100000000.00 | $-3,999,999,996.00 | 0.00 |
| 2010-03-31 | 100000000.00 | $-3,999,999,996.00 | 0.00 |
| 2009-12-31 | 100000000.00 | $-3,999,999,996.00 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.387B | $0.002B |
| Delcath Systems, Inc. has developed a system, the Delcath system, to isolate the liver from the general circulatory system and to administer chemotherapy and other therapeutic agents directly to the liver. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $201.535B | 24.59 |
| Intuitive Surgical (ISRG) | United States | $192.187B | 100.48 |
| Edwards Lifesciences (EW) | United States | $43.244B | 27.46 |
| Alcon (ALC) | Switzerland | $41.516B | 27.78 |
| IQVIA Holdings (IQV) | United States | $36.129B | 19.91 |
| IDEXX Laboratories (IDXX) | United States | $35.383B | 41.67 |
| DexCom (DXCM) | United States | $30.150B | 45.41 |
| Waters (WAT) | United States | $22.460B | 33.21 |
| STERIS (STE) | Ireland | $21.145B | 24.34 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.656B | 0.00 |
| Hologic (HOLX) | United States | $16.714B | 18.05 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.878B | 14.25 |
| Sysmex ADR (SSMXY) | Japan | $11.893B | 37.30 |
| Globus Medical (GMED) | United States | $11.223B | 28.42 |
| Masimo (MASI) | United States | $9.431B | 45.63 |
| Penumbra (PEN) | United States | $9.424B | 92.31 |
| Teleflex (TFX) | United States | $8.366B | 13.34 |
| Glaukos (GKOS) | United States | $7.660B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.657B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.653B | 26.37 |
| Veracyte (VCYT) | United States | $3.350B | 100.51 |
| Inari Medical (NARI) | United States | $3.254B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.797B | 16.14 |
| Nihon Kohden (NHNKY) | Japan | $2.380B | 18.08 |
| Elekta AB (EKTAY) | Sweden | $2.206B | 19.83 |
| TransMedics (TMDX) | United States | $2.157B | 68.36 |
| Tandem Diabetes Care (TNDM) | United States | $2.145B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.854B | 9.69 |
| RxSight (RXST) | United States | $1.503B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.364B | 0.00 |
| Artivion (AORT) | United States | $1.213B | 80.36 |
| Pulse Biosciences (PLSE) | United States | $1.086B | 0.00 |
| OPKO Health (OPK) | United States | $1.085B | 0.00 |
| Paragon 28 (FNA) | United States | $0.872B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.826B | 14.04 |
| Mesa Laboratories (MLAB) | United States | $0.693B | 16.33 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.686B | 0.00 |
| IRadimed (IRMD) | United States | $0.667B | 36.05 |
| AxoGen (AXGN) | United States | $0.623B | 0.00 |
| SiBone (SIBN) | United States | $0.563B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.557B | 32.77 |
| Pacific Biosciences Of California (PACB) | United States | $0.537B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.536B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.467B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.430B | 23.27 |
| ClearPoint Neuro (CLPT) | United States | $0.423B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.366B | 0.00 |
| NeuroPace (NPCE) | United States | $0.329B | 0.00 |
| CVRx (CVRX) | United States | $0.311B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.215B | 0.00 |
| Inogen (INGN) | United States | $0.213B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.197B | 0.00 |
| Accuray (ARAY) | United States | $0.193B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.182B | 0.00 |
| Nevro (NVRO) | United States | $0.153B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.141B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.134B | 14.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.099B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.091B | 0.00 |
| LENSAR (LNSR) | United States | $0.088B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.084B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.082B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.079B | 0.00 |
| InspireMD (NSPR) | Israel | $0.077B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| 908 Devices (MASS) | United States | $0.072B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.064B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.050B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.047B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.043B | 0.00 |
| Envoy Medical (COCH) | United States | $0.040B | 0.00 |
| Neuronetics (STIM) | United States | $0.034B | 0.00 |
| Spectral AI (MDAI) | United States | $0.033B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| NexGel (NXGL) | United States | $0.032B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.029B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.025B | 0.00 |
| DarioHealth (DRIO) | United States | $0.025B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.011B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.010B | 0.00 | |
| PAVmed (PAVM) | United States | $0.008B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |